Emergent Biosolutions Inc (EBS)
SG&A Expenses
$181.10M
TTM · Period ending: · USD
EBS SG&A Expenses
Latest reported$181.10Mperiod ending
Latest reported$181.10Mperiod ending
EBS TTM SG&A Expenses ($352.50M → $181.10M)
TTM SG&A Expenses
High-resolution chart · PNG
EBS sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 181,100,000 | |
| 180,500,000 | |
| 186,600,000 | |
| 196,200,000 | |
| 233,300,000 | |
| 266,600,000 | |
| 298,700,000 | |
| 327,400,000 | |
| 331,200,000 | |
| 345,200,000 | |
| 356,700,000 | |
| 360,700,000 | |
| 362,800,000 | |
| 351,000,000 | |
| 339,500,000 | |
| 340,300,000 | |
| 340,600,000 | |
| 352,300,000 | |
| 348,400,000 | |
| 336,300,000 | |
| 329,700,000 | |
| 314,500,000 | |
| 303,300,000 | |
| 293,400,000 | |
| 282,900,000 | |
| 277,700,000 | |
| 273,400,000 | |
| 277,400,000 | |
| 254,500,000 | |
| 223,200,000 | |
| 197,800,000 | |
| 162,979,000 | |
| 155,382,000 | |
| 147,750,000 | |
| 142,900,000 | |
| 130,942,000 | |
| 133,378,000 | |
| 137,435,000 | |
| 133,998,000 | |
| 139,459,000 | |
| 128,320,000 | |
| 118,665,000 | |
| 121,145,000 | |
| 110,068,000 | |
| 114,560,000 | |
| 118,845,000 | |
| 114,741,000 | |
| 109,057,000 | |
| 100,720,000 | |
| 90,666,000 | |
| 80,605,000 | |
| 81,960,000 | |
| 79,160,000 | |
| 76,554,000 | |
| 76,018,000 | |
| 74,796,000 | |
| 73,073,000 | |
| 75,562,000 | |
| 74,282,000 | |
| 77,699,000 | |
| 80,960,000 | |
| 78,225,000 | |
| 76,205,000 | |
| 73,205,000 | |
| 72,279,000 | |
| 74,003,000 | |
| 73,786,000 | |
| 68,979,000 | |
| 63,327,000 | |
| 58,993,000 | |
| 55,078,000 | |
| 57,880,000 | |
| 58,803,000 | |
| 56,423,000 | |
| 55,556,000 | |
| 50,539,000 | |
| 46,485,000 | |
| 33,826,000 | |
| 22,633,000 | |
| 10,984,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 94,200,000 | |
| 176,300,000 | |
| 267,700,000 | |
| 352,500,000 | |
| 352,500,000 |